DISCLAIMER
These codes are currently under development by the LOINC team, and are subject to change prior to inclusion in a public release. It is possible that they may not be published in the next, or any, public release. They are provided here for informational purposes only.
SPECIAL USE
Special Use codes are developed in response to an urgent or emergent situation. These codes are based on the most up to date information available at the time of their creation. They have undergone the normal QA terminology process. LOINC supports their use in the unique situation that resulted in their rapid creation. However, be aware that downstream users may not be ready to handle prerelease codes until they are published in an official release.
Guidance for mapping to SARS-CoV-2 LOINC terms
Full list of LOINCs related to SARS-CoV-2/COVID-19
The page linked above includes an option to export terms in CSV format.
Receive email notices of new Special Use LOINC terms
scroll/swipe to view more columns
| Created On | LOINC | Long Common Name | Special Use | Component | Prop | Time | System | Scale | Method | Shortname |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-13 | 101406-7 | Sudan virus RNA [Presence] in Blood by NAA with probe detection | 1 | Sudan virus RNA | PrThr | Pt | Bld | Ord | Probe.amp.tar | Sudan virus RNA Bld Ql NAA+probe |
| 2023-01-10 | 101399-4 | Monkeypox virus and Orthopoxvirus.non-variola DNA [Identifier] in Specimen by NAA with probe detection | 1 | Monkeypox virus & Orthopoxvirus.non-variola DNA | Prid | Pt | XXX | Nom | Probe.amp.tar | MVPX & Nonvar Orthpx DNA Spec NAA+probe |
| 2023-01-10 | 101398-6 | Monkeypox virus and Orthopoxvirus.non-variola DNA panel - Specimen | 1 | Monkeypox virus & Orthopoxvirus.non-variola DNA panel | - | Pt | XXX | - | MVPX & Nonvar Orthpx DNA panel Spec | |
| 2023-01-09 | 101373-9 | Francisella tularensis DNA [Presence] in Sputum by NAA with non-probe detection | 1 | Francisella tularensis DNA | PrThr | Pt | Sputum | Ord | Non-probe.amp.tar | F tular DNA Spt Ql NAA+non-probe |
| 2023-01-09 | 101371-3 | Yersinia pestis DNA [Presence] by NAA with non-probe detection in Positive blood culture | 1 | Yersinia pestis DNA | PrThr | Pt | Bld.pos growth | Ord | Non-probe.amp.tar | Y pestis DNA Bld Pos Ql NAA+non-probe |
| 2023-01-09 | 101372-1 | Yersinia pestis DNA [Presence] in Sputum by NAA with non-probe detection | 1 | Yersinia pestis DNA | PrThr | Pt | Sputum | Ord | Non-probe.amp.tar | Y pestis DNA Spt Ql NAA+non-probe |
| 2023-01-09 | 101370-5 | Bacillus anthracis plasmid pXO2 DNA [Presence] by NAA with non-probe detection in Positive blood culture | 1 | Bacillus anthracis plasmid pXO2 DNA | PrThr | Pt | Bld.pos growth | Ord | Non-probe.amp.tar | B anthracis plasmid pXO2 DNA Bld Pos Ql |
| 2023-01-09 | 101369-7 | Bacillus anthracis plasmid pXO1 DNA [Presence] by NAA with non-probe detection in Positive blood culture | 1 | Bacillus anthracis plasmid pXO1 DNA | PrThr | Pt | Bld.pos growth | Ord | Non-probe.amp.tar | B anthracis plasmid pXO1 DNA Bld Pos Ql |
| 2023-01-09 | 101367-1 | Marburg virus RNA [Presence] in Blood by NAA with non-probe detection | 1 | Marburg virus RNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | MARV RNA Bld Ql NAA+non-probe |
| 2023-01-09 | 101368-9 | Bacillus anthracis DNA [Presence] by NAA with non-probe detection in Positive blood culture | 1 | Bacillus anthracis DNA | PrThr | Pt | Bld.pos growth | Ord | Non-probe.amp.tar | B anthracis DNA Bld Pos Ql NAA+non-probe |
| 2023-01-09 | 101365-5 | Coxiella burnetii DNA [Presence] in Blood by NAA with non-probe detection | 1 | Coxiella burnetii DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | C burnet DNA Bld Ql NAA+non-probe |
| 2023-01-09 | 101366-3 | Ebola virus RNA [Presence] in Blood by NAA with non-probe detection | 1 | Ebola virus RNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | EBOV RNA Bld Ql NAA+non-probe |
| 2023-01-09 | 101363-0 | Yersinia pestis DNA [Presence] in Blood by NAA with non-probe detection | 1 | Yersinia pestis DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | Y pestis DNA Bld Ql NAA+non-probe |
| 2023-01-09 | 101364-8 | Francisella tularensis DNA [Presence] in Blood by NAA with non-probe detection | 1 | Francisella tularensis DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | F tular DNA Bld Ql NAA+non-probe |
| 2023-01-09 | 101362-2 | Bacillus anthracis DNA [Presence] in Blood by NAA with non-probe detection | 1 | Bacillus anthracis DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | B anthracis DNA Bld Ql NAA+non-probe |
| 2023-01-09 | 101360-6 | Bacillus anthracis plasmid pXO1 DNA [Presence] in Blood by NAA with non-probe detection | 1 | Bacillus anthracis plasmid pXO1 DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | B anthracis plasmid pXO1 DNA Bld Ql NAA+ |
| 2023-01-09 | 101361-4 | Bacillus anthracis plasmid pXO2 DNA [Presence] in Blood by NAA with non-probe detection | 1 | Bacillus anthracis plasmid pXO2 DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | B anthracis plasmid pXO2 DNA Bld Ql NAA+ |
| 2023-01-09 | 101359-8 | Bioterrorism agent panel - Specimen by NAA with non-probe detection | 1 | Bioterrorism agent panel | - | Pt | XXX | - | Non-probe.amp.tar | Bioterrorism agent panel Spec NAA+non-pr |
| 2022-10-07 | 101004-0 | Monkeypox virus lineage [Identifier] in Specimen by Sequencing | 1 | Monkeypox virus lineage | Type | Pt | XXX | Nom | Sequencing | MVPX lineage Spec Seq |
| 2022-10-07 | 101003-2 | Monkeypox virus clade [Type] in Specimen by Sequencing | 1 | Monkeypox virus clade | Type | Pt | XXX | Nom | Sequencing | MVPX clade Spec Seq |
| 2022-10-07 | 101002-4 | Monkeypox virus sequencing panel - Specimen by Sequencing | 1 | Monkeypox virus sequencing panel | - | Pt | XXX | - | Sequencing | MVPX sequencing panel Spec Seq |
| 2023-01-12 | 101405-9 | Amyloid protein in Tissue Document | Amyloid protein | Find | Pt | Tiss | Doc | Congo red stain+LC/MS/MS | ||
| 2023-01-11 | 101403-4 | Borrelia burgdorferi.VlsE1+pepC10 IgG+IgM Ab [Presence] in Serum by Immunoassay | Borrelia burgdorferi.VlsE1+pepC10 Ab.IgG+IgM | PrThr | Pt | Ser | Ord | IA | ||
| 2023-01-11 | 101402-6 | Phenylalanine and Tyrosine panel - Serum or Plasma | Phenylalanine & Tyrosine panel | - | Pt | Ser/Plas | - | |||
| 2023-01-11 | 101401-8 | Tapentadol and Nortapentadol panel - Urine | Tapentadol & Nortapentadol panel | - | Pt | Urine | - | |||
| 2023-01-11 | 101400-0 | Metanephrine, Normetanephrine, 3-Methoxytyramine panel - 24 hour Urine | Metanephrine, Normetanephrine, 3-Methoxytyramine panel | - | 24H | Urine | - | |||
| 2023-01-10 | 101397-8 | Copy number variation analysis in Blood or Tissue by Sequencing | Copy number variation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | ||
| 2023-01-10 | 101396-0 | Preimplantation multigene analysis in Embryo by Molecular genetics method | Preimplantation multigene analysis | Find | Pt | ^Embryo | Doc | Molgen | ||
| 2023-01-10 | 101395-2 | Translocation analysis in Embryo by Molecular genetics method | Translocation analysis | Find | Pt | ^Embryo | Doc | Molgen | ||
| 2023-01-10 | 101394-5 | Sex [Type] in Embryo by Molecular genetics method | Sex | Type | Pt | ^Embryo | Nom | Molgen | ||
| 2023-01-10 | 101393-7 | CLCN7 gene full mutation analysis in Blood or Tissue by Molecular genetics method | CLCN7 gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2023-01-10 | 101391-1 | PAH gene full mutation analysis in Blood or Tissue by Molecular genetics method | PAH gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2023-01-10 | 101392-9 | ADA gene full mutation analysis in Blood or Tissue by Molecular genetics method | ADA gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2023-01-10 | 101389-5 | GP1BA gene full mutation analysis in Blood or Tissue by Molecular genetics method | GP1BA gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2023-01-10 | 101390-3 | GP9 gene full mutation analysis in Blood or Tissue by Molecular genetics method | GP9 gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2023-01-10 | 101388-7 | GP1BB full mutation analysis in Blood or Tissue by Molecular genetics method | GP1BB gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2023-01-10 | 101387-9 | HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Molecular genetics method | HBA1 & HBA2 gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2023-01-09 | 101376-2 | Megakaryocytes [Presence] in Blood by Light microscopy | Megakaryocytes | PrThr | Pt | Bld | Ord | Microscopy.light | ||
| 2023-01-09 | 101375-4 | Troponin I.cardiac [Mass concentration difference] in Serum or Plasma by Calculation --2H post baseline measurement | Troponin I.cardiac^2H post baseline measurement | MCncDiff | Pt | Ser/Plas | Qn | Calculation | ||
| 2023-01-09 | 101374-7 | Referral has been made to the local contact agency Patient education material [CMS Assessment] | Referral has been made to the local contact agency | Find | - | Patient education material | Ord | CMS Assessment | ||
| 2023-01-06 | 101358-0 | Borrelia burgdorferi Ab [Interpretation] in Serum by IA.MTTT | Borrelia burgdorferi Ab | Imp | Pt | Ser | Nom | IA.MTTT | ||
| 2023-01-06 | 101357-2 | Borrelia burgdorferi.VlsE+OspC IgG+IgM Ab [Presence] in Serum by Immunoassay | Borrelia burgdorferi.VlsE+OspC Ab.IgG+IgM | PrThr | Pt | Ser | Ord | IA | ||
| 2023-01-06 | 101355-6 | Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Immunoassay | Borrelia afzelii+burgdorferi+garinii Ab.IgM | PrThr | Pt | Ser | Ord | IA | ||
| 2023-01-06 | 101356-4 | Borrelia afzelii+burgdorferi+garinii Ab [Interpretation] in Serum by IA.MTTT | Borrelia afzelii+burgdorferi+garinii Ab | Imp | Pt | Ser | Nom | IA.MTTT | ||
| 2023-01-06 | 101354-9 | Borrelia afzelii+burgdorferi+garinii IgG+IgM Ab [Presence] in Serum by Immunoassay | Borrelia afzelii+burgdorferi+garinii Ab.IgG+IgM | PrThr | Pt | Ser | Ord | IA | ||
| 2023-01-06 | 101353-1 | Borrelia burgdorferi Ab [Interpretation] in Serum Qualitative by IA.MTTT | Borrelia burgdorferi Ab | Imp | Pt | Ser | Ord | IA.MTTT | ||
| 2023-01-06 | 101352-3 | Borrelia burgdorferi Ab.IgG and IgM with reflex to immunoassay panel - Serum or Plasma | Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel | - | Pt | Ser/Plas | - | |||
| 2023-01-05 | 101351-5 | Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living [CMS Assessment] | Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living | Find | Pt | *^Patient | Nom | CMS Assessment | ||
| 2023-01-05 | 101350-7 | Orthopaedic + Trauma Surgery Consult note | Consultation note | Find | Pt | {Setting} | Doc | Orthopaedic+Trauma Surgery | ||
| 2023-01-04 | 101349-9 | Jurisdiction where advance directive is accepted [Location] | Jurisdiction where advance directive is accepted | Loc | Pt | ^Patient | Nom | |||
| 2023-01-04 | 101348-1 | Palmitoyl protein thioesterase and Tripeptidyl peptidase I panel - DBS | Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel | - | Pt | Bld.dot | - | |||
| 2023-01-03 | 101347-3 | Return to community [CMS Assessment] | Return to Community | - | Pt | *^Patient | - | CMS Assessment | ||
| 2023-01-03 | 101346-5 | Special Treatments, Procedures, and Programs | - | Pt | *^Patient | - | CMS Assessment | |||
| 2022-12-20 | 101345-7 | Candida krusei DNA [Presence] in Specimen by NAA with probe detection | Candida krusei DNA | PrThr | Pt | XXX | Ord | Probe.amp.tar | ||
| 2022-12-13 | 101344-0 | Acute febrile illness global pathogens panel - Blood by NAA with non-probe detection | Acute febrile illness global pathogens panel | - | Pt | Bld | - | Non-probe.amp.tar | ||
| 2022-12-13 | 101343-2 | Erythrocytes.parasite sp infected/100 cells in Blood | Erythrocytes.parasite sp infected/100 cells | NFr | Pt | Bld | Qn | |||
| 2022-12-12 | 101342-4 | JC virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | JC virus DNA | ACnc | Pt | Ser/Plas | Qn | Probe.amp.tar | ||
| 2022-12-12 | 101341-6 | BK virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | BK virus DNA | ACnc | Pt | Bld | Qn | Probe.amp.tar | ||
| 2022-12-12 | 101340-8 | Aeromonas sp DNA [Presence] in Stool by NAA with probe detection | Aeromonas sp DNA | PrThr | Pt | Stool | Ord | Probe.amp.tar | ||
| 2022-12-12 | 101339-0 | Cholesterol [Presence] in Fibroblast by Filipin stain | Cholesterol | PrThr | Pt | Fibroblasts | Ord | Filipin stain | ||
| 2022-12-12 | 101338-2 | Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method | Coagulation factor X inhibitor | ACnc | Pt | PPP | Qn | Chromo | ||
| 2022-12-12 | 101337-4 | Treatment preferences under certain health conditions [Reported] | Treatment preferences under certain health conditions | Find | Pt | ^Patient | Nar | Reported | ||
| 2022-12-12 | 101336-6 | Wr sup(b) Ag [Presence] on Red Blood Cells | W little r super little b Ag | PrThr | Pt | RBC | Ord | |||
| 2022-12-07 | 101335-8 | Etizolam [Presence] in Urine by Confirmatory method | Etizolam | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-12-07 | 101334-1 | Etizolam [Mass Ratio] in Urine by Confirmatory method | Etizolam | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-12-06 | 101333-3 | Determination of pressure injury risk [CMS Assessment] | Determination of pressure injury risk | Find | Pt | *^Patient | Nom | CMS Assessment | ||
| 2022-12-06 | 101332-5 | Reason referral to local contact agency not made [CMS Assessment] | Reason referral to local contact agency not made | Find | Pt | *^Patient | Nom | CMS Assessment | ||
| 2022-12-06 | 101331-7 | Ulcers, wounds and skin problems [CMS Assessment] | Ulcers, wounds and skin problems | Find | RptPeriod | *^Patient | Nom | CMS Assessment | ||
| 2022-12-06 | 101330-9 | Number of venous and arterial ulcers [CMS Assessment] | Number of venous and arterial ulcers | Num | RptPeriod | *^Patient | Qn | CMS Assessment | ||
| 2022-12-05 | 101329-1 | Participation in assessment and goal setting [CMS Assessment] | Participation in assessment and goal setting | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-12-05 | 101328-3 | Nutritional approaches - at discharge [CMS Assessment] | Nutritional approaches - at discharge | Find | RptPeriod | *^Patient | Nom | CMS Assessment | ||
| 2022-12-05 | 101327-5 | Nutritional approaches - on admission [CMS Assessment] | Nutritional approaches - on admission | Find | RptPeriod | *^Patient | Nom | CMS Assessment | ||
| 2022-12-02 | 101326-7 | Pain assessment interview [CMS Assessment] | Pain assessment interview | - | RptPeriod | *^Patient | - | CMS Assessment | ||
| 2022-12-02 | 101325-9 | Tub/shower transfer - functional goal | Tub &or shower transfer - functional goal | Find | Pt | *^Patient | Ord | CMS Assessment | ||
| 2022-12-02 | 101324-2 | Mobility - Discharge Goal [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal | - | RptPeriod | *^Patient | - | CMS Assessment | ||
| 2022-12-02 | 101323-4 | Mobility - Admission Performance [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance | - | RptPeriod | *^Patient | - | CMS Assessment | ||
| 2022-12-01 | 101322-6 | MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal | - | RptPeriod | *^Patient | - | CMS Assessment | |||
| 2022-12-01 | 101321-8 | MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance | - | RptPeriod | *^Patient | - | CMS Assessment | |||
| 2022-11-30 | 101318-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin | 17-Hydroxypregnenolone^1H post dose corticotropin | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-11-30 | 101319-2 | Cortisol and Cortisone panel - 24 hour Urine | Cortisol & Cortisone panel | - | 24H | Urine | - | |||
| 2022-11-30 | 101317-6 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin | 17-Hydroxypregnenolone^30M post dose corticotropin | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-11-30 | 101316-8 | Cortisol and 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma | Cortisol & 17-Hydroxyprogesterone post corticotropin stimulation panel | - | Pt | Ser/Plas | - | |||
| 2022-11-30 | 101315-0 | Cortisol and Cortisone panel - Urine | Cortisol & Cortisone panel | - | Pt | Urine | - | |||
| 2022-11-30 | 101314-3 | 17-Hydroxypregnenolone and 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma | 17-Hydroxypregnenolone & 17-Hydroxyprogesterone post corticotropin stimulation panel | - | Pt | Ser/Plas | - | |||
| 2022-11-30 | 101313-5 | 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma | 17-Hydroxyprogesterone post corticotropin stimulation panel | - | Pt | Ser/Plas | - | |||
| 2022-11-30 | 101311-9 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin | 17-Hydroxyprogesterone^30M post dose corticotropin | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-11-30 | 101312-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin | 17-Hydroxyprogesterone^1H post dose corticotropin | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-11-30 | 101310-1 | Somatotropin post insulin stimulation panel - Serum or Plasma | Somatotropin post insulin stimulation panel | - | Pt | Ser/Plas | - | |||
| 2022-11-30 | 101309-3 | Glucose [Mass/volume] in Plasma --2 hours post dose arginine | Glucose^2H post dose arginine | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-11-30 | 101308-5 | Glucose post arginine stimulation panel - Serum or Plasma | Glucose post arginine stimulation panel | - | Pt | Ser/Plas | - | |||
| 2022-11-30 | 101307-7 | Plasmodium vivax+ovale DNA [Presence] in Blood by NAA with non-probe detection | Plasmodium vivax+ovale | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101305-1 | Plasmodium sp DNA [Presence] in Blood by NAA with non-probe detection | Plasmodium sp DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101306-9 | Plasmodium falciparum DNA [Presence] in Blood by NAA with non-probe detection | Plasmodium falciparum DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101303-6 | Chikungunya virus RNA [Presence] in Blood by NAA with non-probe detection | Chikungunya virus RNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101304-4 | Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with non-probe detection | Dengue virus 1+2+3+4 RNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101302-8 | Leptospira sp DNA [Presence] in Blood by NAA with non-probe detection | Leptospira sp DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101301-0 | XR Thoracic spine Views 2 and Abdomen AP and Lateral | Views 2 && Views AP + lateral | Find | Pt | Chest>Spine.thoracic && Abdomen | Doc | XR | ||
| 2022-11-30 | 101299-6 | Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Throat by NAA with non-probe detection | Streptococcus dysgalactiae subspecies equisimilis DNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101300-2 | Streptococcus pyogenes DNA [Presence] in Throat by NAA with non-probe detection | Streptococcus pyogenes DNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101297-0 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Throat by NAA with non-probe detection | Parainfluenza virus 1+2+3+4 RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101298-8 | Respiratory syncytial virus RNA [Presence] in Throat by NAA with non-probe detection | Respiratory syncytial virus RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101294-7 | Influenza virus A H3 RNA [Presence] in Throat by NAA with non-probe detection | Influenza virus A H3 RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101295-4 | Influenza virus B RNA [Presence] in Throat by NAA with non-probe detection | Influenza virus B RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101296-2 | Mycoplasma pneumoniae DNA [Presence] in Throat by NAA with non-probe detection | Mycoplasma pneumoniae DNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101292-1 | Influenza virus A RNA [Presence] in Throat by NAA with non-probe detection | Influenza virus A RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101293-9 | Influenza virus A H1 2009 pandemic RNA [Presence] in Throat by NAA with non-probe detection | Influenza virus A H1 2009 pandemic RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101290-5 | Human metapneumovirus RNA [Presence] in Throat by NAA with non-probe detection | Human metapneumovirus RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101291-3 | Rhinovirus+Enterovirus RNA [Presence] in Throat by NAA with non-probe detection | Rhinovirus+Enterovirus RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101287-1 | Chlamydophila pneumoniae DNA [Presence] in Throat by NAA with non-probe detection | Chlamydophila pneumoniae DNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101288-9 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Throat by NAA with non-probe detection | Human coronavirus 229E+HKU1+NL63+OC43 RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101289-7 | SARS-CoV-2 (COVID-19) RNA [Presence] in Throat by NAA with non-probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101285-5 | Pharyngeal pathogens DNA and RNA panel - Throat by NAA with non-probe detection | Pharyngeal pathogens DNA & RNA panel | - | Pt | Thrt | - | Non-probe.amp.tar | ||
| 2022-11-30 | 101286-3 | Adenovirus DNA [Presence] in Throat by NAA with non-probe detection | Adenovirus DNA | PrThr | Pt | Thrt | Ord | Non-probe.amp.tar | ||
| 2022-11-30 | 101284-8 | Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with non-probe detection | Bordetella pertussis DNA | PrThr | Pt | Nph | Ord | Non-probe.amp.tar | ||
| 2022-11-29 | 101283-0 | Speciociliatine [Presence] in Umbilical cord | Speciociliatine | PrThr | Pt | TissCo | Ord | |||
| 2022-11-29 | 101282-2 | Mitragynine [Presence] in Umbilical cord | Mitragynine | PrThr | Pt | TissCo | Ord | |||
| 2022-11-29 | 101281-4 | Neurofilament light chain [Mass/volume] in Serum or Plasma by Immunoassay | Neurofilament light chain | MCnc | Pt | Ser/Plas | Qn | IA | ||
| 2022-11-28 | 101279-8 | MDS v3.0 - RAI v1.18.11 - Correction Request [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Correction Request | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101280-6 | MDS v3.0 - RAI v1.18.11 - Assessment Administration [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Assessment Administration | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101278-0 | MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101277-2 | MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101275-6 | MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101276-4 | MDS v3.0 - RAI v1.18.11 - Restraints and Alarms [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Restraints and Alarms | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101274-9 | MDS v3.0 - RAI v1.18.11 - Medications | MDS v3.0 - RAI v1.18.11 - Medications | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101273-1 | MDS v3.0 - RAI v1.18.11 - Skin Conditions [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Skin Conditions | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101271-5 | MDS v3.0 - RAI v1.18.11 - Swallowing/Nutritional Status [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Swallowing &or Nutritional Status | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101272-3 | MDS v3.0 - RAI v1.18.11 - Oral/Dental Status [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Oral &or Dental Status | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101270-7 | MDS v3.0 - RAI v1.18.11 - Health Conditions [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Health Conditions | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101269-9 | MDS v3.0 - RAI v1.18.11 - Active Diagnoses [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Active Diagnoses | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101267-3 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA/Interim [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA &or Interim | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101268-1 | MDS v3.0 - RAI v1.18.11 - Bladder and Bowel [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Bladder and Bowel | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101266-5 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101265-7 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101263-2 | MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101264-0 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101262-4 | MDS v3.0 - RAI v1.18.11 - Behavior [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Behavior | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101261-6 | MDS v3.0 - RAI v1.18.11 - Mood [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Mood | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101259-0 | MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101260-8 | MDS v3.0 - RAI v1.18.11 - Cognitive Patterns [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Cognitive Patterns | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101258-2 | MDS v3.0 - RAI v1.18.11 - Identification Information [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Identification Information | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-28 | 101256-6 | Silica clotting time actual/normal of Platelet poor plasma | Silica clotting time | RelTime | Pt | PPP | Qn | |||
| 2022-11-28 | 101257-4 | Silica clotting time W excess phospholipid actual/normal of Platelet poor plasma | Silica clotting time.excess phospholipid actual/Normal | RelTime | Pt | PPP | Qn | |||
| 2022-11-28 | 101255-8 | Herpes virus 6 DNA [Units/volume] (viral load) in Blood by NAA with probe detection | Herpes virus 6 DNA | ACnc | Pt | Bld | Qn | Probe.amp.tar | ||
| 2022-11-28 | 101254-1 | Herpes virus 6 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | Herpes virus 6 DNA | ACnc | Pt | Ser/Plas | Qn | Probe.amp.tar | ||
| 2022-11-28 | 101253-3 | Thrombin generation test [Interpretation] in Platelet poor plasma Narrative | Thrombin generation test | Imp | Pt | PPP | Nar | |||
| 2022-11-28 | 101252-5 | Urea [Mass/volume] in Dialysis fluid | Urea | MCnc | Pt | Dial fld | Qn | |||
| 2022-11-28 | 101251-7 | Dense fine speckled 70 protein Ab [Presence] in Serum or Plasma | Dense fine speckled 70 protein Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-28 | 101250-9 | Aspergillus fumigatus [Presence] in Isolate | Aspergillus fumigatus | PrThr | Pt | Isolate | Ord | |||
| 2022-11-28 | 101249-1 | Delta-8-tetrahydrocannabinol [Mass/volume] in Urine by LC/MS/MS | Delta-8-tetrahydrocannabinol | MCnc | Pt | Urine | Qn | LC/MS/MS | ||
| 2022-11-28 | 101248-3 | Pathologic casts [Presence] in Urine sediment by Light microscopy | Pathologic casts | PrThr | Pt | Urine sed | Ord | Microscopy.light | ||
| 2022-11-28 | 101246-7 | NMDAR Ab [Presence] in Serum or Plasma by Immunofluorescence | N-methyl-D-aspartate receptor Ab | PrThr | Pt | Ser/Plas | Ord | IF | ||
| 2022-11-28 | 101247-5 | NMDAR Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | N-methyl-D-aspartate receptor Ab | PrThr | Pt | CSF | Ord | IF | ||
| 2022-11-28 | 101244-2 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Leucine-rich glioma-inactivated protein 1 Ab | PrThr | Pt | CSF | Ord | IF | ||
| 2022-11-28 | 101245-9 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Serum or Plasma by Immunofluorescence | Leucine-rich glioma-inactivated protein 1 Ab | PrThr | Pt | Ser/Plas | Ord | IF | ||
| 2022-11-28 | 101242-6 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Dipeptidyl aminopeptidase-like protein 6 Ab | PrThr | Pt | CSF | Ord | IF | ||
| 2022-11-28 | 101243-4 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum or Plasma by Immunofluorescence | Dipeptidyl aminopeptidase-like protein 6 Ab | PrThr | Pt | Ser/Plas | Ord | IF | ||
| 2022-11-28 | 101241-8 | Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Contactin-associated protein 2 Ab | PrThr | Pt | CSF | Ord | IF | ||
| 2022-11-28 | 101239-2 | Mean chromosome banding resolution [#] in Blood or Tissue by Banding | Mean chromosome banding resolution | Num | Pt | Bld/Tiss | Qn | Banding | ||
| 2022-11-28 | 101240-0 | Contactin-associated protein 2 Ab [Presence] in Serum or Plasma by Immunofluorescence | Contactin-associated protein 2 Ab | PrThr | Pt | Ser/Plas | Ord | IF | ||
| 2022-11-28 | 101237-6 | Titin Ab [Presence] in Serum by Immunoblot | Titin Ab | PrThr | Pt | Ser | Ord | IB | ||
| 2022-11-28 | 101238-4 | Spermatozoa Immotile/100 spermatozoa in Semen --post vasectomy | Spermatozoa.immotile/100 spermatozoa^post vasectomy | NFr | Pt | Semen | Qn | |||
| 2022-11-28 | 101236-8 | Titin Ab [Presence] in Cerebral spinal fluid by Immunoblot | Titin Ab | PrThr | Pt | CSF | Ord | IB | ||
| 2022-11-28 | 101234-3 | Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot | Glial nuclear type 1 Ab | PrThr | Pt | CSF | Ord | IB | ||
| 2022-11-28 | 101235-0 | Glial nuclear type 1 Ab [Presence] in Serum by Immunoblot | Glial nuclear type 1 Ab | PrThr | Pt | Ser | Ord | IB | ||
| 2022-11-28 | 101232-7 | Glutamate decarboxylase 65 Ab [Presence] in Cerebral spinal fluid by Immunoblot | Glutamate decarboxylase 65 Ab | PrThr | Pt | CSF | Ord | IB | ||
| 2022-11-28 | 101233-5 | Glutamate decarboxylase 65 Ab [Presence] in Serum by Immunoblot | Glutamate decarboxylase 65 Ab | PrThr | Pt | Ser | Ord | IB | ||
| 2022-11-28 | 101230-1 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Immunoblot | Zinc finger protein of the cerebellum 4 Ab | PrThr | Pt | CSF | Ord | IB | ||
| 2022-11-28 | 101231-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunoblot | Neuronal nuclear Ab | PrThr | Pt | CSF | Ord | IB | ||
| 2022-11-28 | 101229-3 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum by Immunoblot | Zinc finger protein of the cerebellum 4 Ab | PrThr | Pt | Ser | Ord | IB | ||
| 2022-11-28 | 101227-7 | Recoverin Ab [Presence] in Cerebral spinal fluid by Immunoblot | Recoverin Ab | PrThr | Pt | CSF | Ord | IB | ||
| 2022-11-28 | 101228-5 | PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunoblot | Purkinje cell cytoplasmic type Tr Ab | PrThr | Pt | CSF | Ord | IB | ||
| 2022-11-28 | 101225-1 | Hemosiderin [Presence] in Blood or Marrow by Prussian blue stain | Hemosiderin | PrThr | Pt | Bld/Bone mar | Ord | Prussian blue stain | ||
| 2022-11-28 | 101226-9 | Recoverin Ab [Presence] in Serum by Immunoblot | Recoverin Ab | PrThr | Pt | Ser | Ord | IB | ||
| 2022-11-28 | 101224-4 | PKD1 and PKD2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | PKD1 gene & PKD2 gene deletion+duplication | Find | Pt | Bld/Tiss | Doc | MLPA | ||
| 2022-11-28 | 101223-6 | Normorphine/Creatinine [Mass Ratio] in Urine | Normorphine/Creatinine | MRto | Pt | Urine | Qn | |||
| 2022-11-28 | 101222-8 | Meropenem+Vaborbactam [Susceptibility] by Disk diffusion (KB) | Meropenem+Vaborbactam | Susc | Pt | Isolate | OrdQn | Agar diffusion | ||
| 2022-11-28 | 101221-0 | PM-SCL-100 extractable nuclear Ab [Units/volume] in Serum by Immunoassay | PM-SCL-100 extractable nuclear Ab | ACnc | Pt | Ser | Qn | IA | ||
| 2022-11-28 | 101220-2 | SUMO-activating enzyme subunit 1 IgG Ab [Units/volume] in Serum | SUMO-activating enzyme subunit 1 Ab.IgG | ACnc | Pt | Ser | Qn | IA | ||
| 2022-11-28 | 101218-6 | Hantavirus dobrava IgM Ab [Presence] in Serum or Plasma by Line blot | Hantavirus dobrava Ab.IgM | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101219-4 | Legionella sp DNA [Presence] in Specimen by NAA with probe detection | Legionella sp DNA | PrThr | Pt | XXX | Ord | Probe.amp.tar | ||
| 2022-11-28 | 101216-0 | Hantavirus sin nombre IgM Ab [Presence] in Serum or Plasma by Line blot | Hantavirus sin nombre Ab.IgM | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101217-8 | Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Line blot | Hantavirus hantaan Ab.IgM | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101214-5 | Hantavirus IgM panel - Serum or Plasma by Line blot | Hantavirus Ab.IgM panel | - | Pt | Ser/Plas | - | Line blot | ||
| 2022-11-28 | 101215-2 | Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Line blot | Hantavirus puumala Ab.IgM | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101213-7 | Hantavirus dobrava IgG Ab [Presence] in Serum or Plasma by Line blot | Hantavirus dobrava | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101211-1 | Hantavirus sin nombre IgG Ab [Presence] in Serum or Plasma by Line blot | Hantavirus sin nombre Ab.IgG | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101212-9 | Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Line blot | Hantavirus hantaan Ab.IgG | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101209-5 | Hantavirus IgG panel - Serum or Plasma by Line blot | Hantavirus Ab.IgG panel | - | Pt | Ser/Plas | - | Line blot | ||
| 2022-11-28 | 101210-3 | Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Line blot | Hantavirus puumala Ab.IgG | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101207-9 | Hepatitis E virus IgG Ab [Presence] in Serum or Plasma by Line blot | Hepatitis E virus Ab.IgG | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101208-7 | Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Line blot | Hepatitis E virus Ab.IgM | PrThr | Pt | Ser/Plas | Ord | Line blot | ||
| 2022-11-28 | 101206-1 | Dengue virus NS1 Ag [Units/volume] in Serum or Plasma by Immunoassay | Dengue virus NS1 Ag | ACnc | Pt | Ser/Plas | Qn | IA | ||
| 2022-11-28 | 101204-6 | Varicella zoster virus IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | Varicella zoster virus Ab.IgA | ACnc | Pt | Ser/Plas | Qn | IA | ||
| 2022-11-28 | 101205-3 | Plasmodium sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | Plasmodium sp Ab.IgG | ACnc | Pt | Ser/Plas | Qn | IA | ||
| 2022-11-28 | 101202-0 | Mumps virus IgG Ab index [Units/volume] in Serum and CSF | Mumps virus Ab.IgG index | ACnc | Pt | Ser+CSF | Qn | |||
| 2022-11-28 | 101203-8 | Herpes simplex virus 1+2 IgG Ab index [Units/volume] in Serum and CSF | Herpes simplex virus 1+2 Ab.IgG index | ACnc | Pt | Ser+CSF | Qn | |||
| 2022-11-28 | 101201-2 | Measles virus IgG Ab index [Units/volume] in Serum and CSF | Measles virus Ab.IgG index | ACnc | Pt | Ser+CSF | Qn | |||
| 2022-11-28 | 101200-4 | Protein.monoclonal band 6/Protein.total in Serum or Plasma by Electrophoresis | Protein.monoclonal band 6/Protein.total | MFr | Pt | Ser/Plas | Qn | Electrophoresis | ||
| 2022-11-28 | 101199-8 | Protein.monoclonal band 5/Protein.total in Serum or Plasma by Electrophoresis | Protein.monoclonal band 5/Protein.total | MFr | Pt | Ser/Plas | Qn | Electrophoresis | ||
| 2022-11-22 | 101198-0 | Albumin [Mass/volume] in Serum or Plasma by Nephelometry | Albumin | MCnc | Pt | Ser/Plas | Qn | Nephelometry | ||
| 2022-11-22 | 101197-2 | Lymph nodes with metastasis/Lymph nodes examined in Colorectal cancer specimen | Lymph nodes with metastasis/Lymph nodes examined | NFr | Pt | Colorectal cancer specimen | Qn | |||
| 2022-11-22 | 101196-4 | Inflammatory cell infiltrate in Colorectal cancer specimen | Inflammatory cell infiltrate | Find | Pt | Colorectal cancer specimen | Nom | |||
| 2022-11-22 | 101195-6 | Depth of invasion beyond muscularis propria [Length] in Colorectal cancer specimen | Depth of invasion beyond muscularis propria | Len | Pt | Colorectal cancer specimen | Qn | |||
| 2022-11-22 | 101193-1 | Sphincter excision plane [Anatomy] in Colorectal cancer specimen | Sphincter excision plane | Anat | Pt | Colorectal cancer specimen | Nom | |||
| 2022-11-22 | 101194-9 | Mesocolic excision plane [Anatomy] in Colorectal cancer specimen | Mesocolic excision plane | Anat | Pt | Colorectal cancer specimen | Nom | |||
| 2022-11-22 | 101192-3 | 5F-MDMB-PICA [Presence] in Urine by Confirmatory method | 5F-MDMB-PICA | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101191-5 | 5F-MDMB-PICA/Creatinine [Mass Ratio] in Urine by Confirmatory method | 5F-MDMB-PICA/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101189-9 | ADB-BUTINACA [Presence] in Urine by Confirmatory method | ADB-BUTINACA | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101190-7 | 5F-MDMB-PICA [Mass/volume] in Urine by Confirmatory method | 5F-MDMB-PICA | MCnc | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101188-1 | ADB-BUTINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method | ADB-BUTINACA/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101187-3 | ADB-BUTINACA [Mass/volume] in Urine by Confirmatory method | ADB-BUTINACA | MCnc | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101185-7 | 4F-MDMB-BINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method | 4F-MDMB-BINACA/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101186-5 | 4F-MDMB-BINACA [Presence] in Urine by Confirmatory method | 4F-MDMB-BINACA | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101184-0 | 4F-MDMB-BINACA [Mass/volume] in Urine by Confirmatory method | 4F-MDMB-BINACA | MCnc | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101183-2 | MDMB-4en-PINACA [Presence] in Urine by Confirmatory method | MDMB-4en-PINACA | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101182-4 | MDMB-4en-PINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method | MDMB-4en-PINACA/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101181-6 | MDMB-4en-PINACA [Mass/volume] in Urine by Confirmatory method | MDMB-4en-PINACA | MCnc | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101180-8 | 2-methyl-AP-237 [Presence] in Urine by Confirmatory method | 2-methyl AP-237 | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101179-0 | Immunoglobulin light chains.free/Protein.total in 24 hour Urine | Immunoglobulin light chains.free/Protein.total | MFr | 24H | Urine | Qn | |||
| 2022-11-22 | 101178-2 | Pneumocystis jiroveci DNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | Pneumocystis jiroveci DNA | ThreshNum | Pt | Respiratory | Qn | Probe.amp.tar | ||
| 2022-11-22 | 101177-4 | Metanephrine Free/Creatinine [Molar ratio] in Serum or Plasma | Metanephrine.free/Creatinine | SRto | Pt | Ser/Plas | Qn | |||
| 2022-11-22 | 101176-6 | Normetanephrine Free/Creatinine [Molar ratio] in Serum or Plasma | Normetanephrine.free/Creatinine | SRto | Pt | Ser/Plas | Qn | |||
| 2022-11-22 | 101175-8 | 3-Methoxytyramine.free/Creatinine [Molar ratio] in Serum or Plasma | 3-Methoxytyramine.free/Creatinine | SRto | Pt | Ser/Plas | Qn | |||
| 2022-11-22 | 101174-1 | 17-Hydroxyprogesterone [Mass/volume] in Saliva (oral fluid) | 17-Hydroxyprogesterone | MCnc | Pt | Saliva | Qn | |||
| 2022-11-22 | 101173-3 | Melatonin [Moles/volume] in Saliva (oral fluid) | Melatonin | SCnc | Pt | Saliva | Qn | |||
| 2022-11-22 | 101172-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis rRNA panel - Specimen by NAA with probe detection | Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel | - | Pt | XXX | - | Probe.amp.tar | ||
| 2022-11-22 | 101171-7 | 2-methyl-AP-237/Creatinine [Mass Ratio] in Urine by Confirmatory method | 2-Methyl AP-237/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101170-9 | Soluble urokinase plasminogen activator receptor [Mass/volume] in Serum or Plasma | Soluble urokinase plasminogen activator receptor | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-11-22 | 101169-1 | 2-methyl-AP-237 [Mass/volume] in Urine by Confirmatory method | 2-Methyl AP-237 | MCnc | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101168-3 | Metonitazene [Presence] in Urine by Confirmatory method | Metonitazene | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101166-7 | Metonitazene [Mass/volume] in Urine by Confirmatory method | Metonitazene | MCnc | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101167-5 | Metonitazene/Creatinine [Mass Ratio] in Urine by Confirmatory method | Metonitazene/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101164-2 | Brorphine/Creatinine [Mass Ratio] in Urine by Confirmatory method | Brorphine/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101165-9 | Brorphine [Presence] in Urine by Confirmatory method | Brorphine | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101163-4 | Brorphine [Mass/volume] in Urine by Confirmatory method | Brorphine | MCnc | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101161-8 | p-Fluorofentanyl/Creatinine [Mass Ratio] in Urine by Confirmatory method | 4-Fluorofentanyl/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101162-6 | p-Fluorofentanyl [Presence] in Urine by Confirmatory method | 4-Fluorofentanyl | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101160-0 | Flubromazolam [Presence] in Urine by Confirmatory method | Flubromazolam | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101158-4 | Flualprazolam [Presence] in Urine by Confirmatory method | Flualprazolam | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101159-2 | Flubromazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | Flubromazolam/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101156-8 | Alpha hydroxyetizolam [Presence] in Urine by Confirmatory method | Alpha hydroxyetizolam | PrThr | Pt | Urine | Ord | Confirm | ||
| 2022-11-22 | 101157-6 | Flualprazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | Flualprazolam/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101155-0 | Alpha hydroxyetizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | Alpha hydroxyetizolam/Creatinine | MRto | Pt | Urine | Qn | Confirm | ||
| 2022-11-22 | 101154-3 | Calprotectin [Mass/volume] in Serum or Plasma | Calprotectin | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-11-22 | 101153-5 | Chemokine (C-C motif) ligand 14 [Mass/volume] in Urine by Immunoassay | Chemokine (C-C motif) ligand 14 | MCnc | Pt | Urine | Qn | IA | ||
| 2022-11-22 | 101152-7 | Mitochondria whole genome analysis in Blood or Tissue by Molecular genetics method | Mitochondria whole genome analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2022-11-21 | 101151-9 | Right ventricular Cardiac output by Indicator dilution | Cardiac output | VRat | Pt | Heart.ventricle.right | Qn | Indicator dilution | ||
| 2022-11-21 | 101150-1 | Right ventricular Cardiac output by Fick method | Cardiac output | VRat | Pt | Heart.ventricle.right | Qn | Fick | ||
| 2022-11-21 | 101149-3 | Borrelia burgdorferi IgM Ab index [Units/volume] in Serum and CSF | Borrelia burgdorferi Ab.IgM index | ACnc | Pt | Ser+CSF | Qn | |||
| 2022-11-21 | 101148-5 | CD14+CD16- (Classical) Monocytes/100 Monocytes in Blood | Monocytes.CD14+CD16-/100 Monocytes | NFr | Pt | Bld | Qn | |||
| 2022-11-21 | 101147-7 | Monocytes/100 leukocytes in Blood by Flow cytometry (FC) | Monocytes/100 leukocytes | NFr | Pt | Bld | Qn | Flow cytometry | ||
| 2022-11-21 | 101146-9 | Monocyte subsets panel - Blood by Flow cytometry (FC) | Monocyte subsets panel | - | Pt | Bld | - | Flow cytometry | ||
| 2022-11-21 | 101145-1 | Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay --trough | Ustekinumab^trough | MCnc | Pt | Ser/Plas | Qn | IA | ||
| 2022-11-21 | 101144-4 | Ustekinumab & Ustekinumab Ab panel - Serum or Plasma | Ustekinumab & Ustekinumab Ab panel | - | Pt | Ser/Plas | - | |||
| 2022-11-17 | 101143-6 | NAT2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | NAT2 gene product metabolic activity interpretation | Imp | Pt | Bld/Tiss | Ord | Molgen | ||
| 2022-11-17 | 101142-8 | NAT2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | NAT2 gene allele | Geno | Pt | Bld/Tiss | Nom | Molgen | ||
| 2022-11-17 | 101141-0 | NAT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | NAT2 gene targeted mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | ||
| 2022-11-17 | 101140-2 | Salmonella spp Ag [Presence] in Stool by Rapid immunoassay | Salmonella sp Ag | PrThr | Pt | Stool | Ord | IA.rapid | ||
| 2022-11-16 | 101139-4 | Hro Ab [Presence] in Serum or Plasma | H little ro Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-16 | 101138-6 | ER^a Ab [Presence] in Serum or Plasma | ER super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-16 | 101137-8 | MNS29 [Presence] in Serum or Plasma | MNS29 | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-15 | 101136-0 | Radiation oncology End of treatment letter | End of treatment letter | Find | Pt | {Setting} | Doc | Radiation oncology | ||
| 2022-11-15 | 101135-2 | Ambulance Discharge summary | Discharge Summary Note | Find | Pt | Ambulance | Doc | {Role} | ||
| 2022-11-15 | 101134-5 | Appointment reminder | Appointment reminder | Find | Pt | {Setting} | Doc | {Role} | ||
| 2022-11-15 | 101133-7 | Organ and or tissue donation consent Document | Organ and or tissue donation consent | Find | Pt | - | Doc | Patient | ||
| 2022-11-15 | 101132-9 | Glucose post XXX challenge panel - Serum or Plasma | Glucose post XXX challenge panel | - | Pt | Ser/Plas | - | |||
| 2022-11-15 | 101131-1 | B-cell precursors in Bone marrow by Flow cytometry (FC) | B-cell precursors | NFr | Pt | Bone marrow | Qn | Flow cytometry | ||
| 2022-11-15 | 101130-3 | Mast cells/100 cells in Bone marrow by Flow cytometry (FC) | Mast cells/100 cells | NFr | Pt | Bone mar | Qn | Flow cytometry | ||
| 2022-11-15 | 101129-5 | Laboratory device Assay Sensitivity | Assay Sensitivity | Num | Pt | Laboratory device | Qn | |||
| 2022-11-15 | 101128-7 | Theoretical limit of detection [#] in Specimen by calculation | Theoretical limit of detection | Num | Pt | XXX | Qn | Calculated | ||
| 2022-11-14 | 101127-9 | Bacterial carbapenem resistance blaSIM gene [Presence] by Molecular method | Bacterial carbapenem resistance blaSIM gene | PrThr | Pt | Isolate/Specimen | Ord | Molgen | ||
| 2022-11-14 | 101126-1 | Bacterial carbapenem resistance blaOXA-24+blaOXA-40 genes [Presence] by Molecular method | Bacterial carbapenem resistance blaOXA-24+blaOXA-40 genes | PrThr | Pt | Isolate/Specimen | Ord | Molgen | ||
| 2022-11-14 | 101124-6 | Bacterial carbapenem resistance blaIMI+blaNMC genes [Presence] by Molecular method | Bacterial carbapenem resistance blaIMI+blaNMC genes | PrThr | Pt | Isolate/Specimen | Ord | Molgen | ||
| 2022-11-14 | 101125-3 | Bacterial carbapenem resistance blaOXA-235-like gene [Presence] by Molecular method | Bacterial carbapenem resistance blaOXA-235-like gene | PrThr | Pt | Isolate/Specimen | Ord | Molgen | ||
| 2022-11-14 | 101123-8 | Bacterial carbapenem resistance blaIMI gene [Presence] by Molecular method | Bacterial carbapenem resistance blaIMI gene | PrThr | Pt | Isolate/Specimen | Ord | Molgen | ||
| 2022-11-14 | 101122-0 | Mephobarbital [Mass/volume] in Blood by Confirmatory method | Mephobarbital | MCnc | Pt | Bld | Qn | Confirm | ||
| 2022-11-14 | 101121-2 | Candida albicans and tropicalis DNA [Presence] in Blood by NAA with probe detection | Candida albicans+tropicalis DNA | PrThr | Pt | Bld | Ord | Probe.amp.tar | ||
| 2022-11-14 | 101120-4 | Candida krusei and glabrata DNA [Presence] in Blood by NAA with probe detection | Candida krusei + glabrata DNA | PrThr | Pt | Bld | Ord | Probe.amp.tar | ||
| 2022-11-11 | 101118-8 | Sezary syndrome diagnosis in Blood Document by Flow cytometry (FC) | Sezary syndrome diagnosis | Find | Pt | Bld | Doc | Flow cytometry | ||
| 2022-11-11 | 101119-6 | Leukemia and lymphoma immunophenotyping Unspecified body region Flow cytometry (FC) | Leukemia and lymphoma immunophenotyping | Find | Pt | XXX | Doc | Flow cytometry | ||
| 2022-11-11 | 101117-0 | Sezary syndrome monitoring in Blood Document by Flow cytometry (FC) | Sezary syndrome monitoring | Find | Pt | Bld | Doc | Flow cytometry | ||
| 2022-11-11 | 101116-2 | THSD7A Ag [Presence] in Tissue by Immunofluorescence | Thrombospondin type I domain-containing 7A Ag | PrThr | Pt | Tiss | Ord | IF | ||
| 2022-11-11 | 101115-4 | Leukotriene E4/Creatinine [Mass Ratio] in 24 hour Urine | Leukotriene E4/Creatinine | MRto | 24H | Urine | Qn | |||
| 2022-11-10 | 101114-7 | NCSBN ID | National Council of State Boards of Nurses ID | ID | Pt | Provider | Nom | |||
| 2022-11-09 | 101105-5 | MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set [CMS Assessment] | MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set | - | Pt | ^Patient | - | CMS Assessment | ||
| 2022-11-09 | 101104-8 | Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 [CMS Assessment] | Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 | - | Pt | *^Patient | - | CMS Assessment | ||
| 2022-11-08 | 101103-0 | C^G Ab [Presence] in Serum or Plasma | C super G Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101101-4 | Kx Ab [Presence] in Serum or Plasma | K little x Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101102-2 | Kx Ag [Presence] on Red Blood Cells | K little x Ag | PrThr | Pt | RBC | Ord | |||
| 2022-11-07 | 101100-6 | Ku Ag [Presence] on Red Blood Cells | K little u Ag | PrThr | Pt | RBC | Ord | |||
| 2022-11-07 | 101099-0 | Km Ab [Presence] in Serum or Plasma | K little m Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101098-2 | JMH Ag [Presence] on Red Blood Cells | JMH Ag | PrThr | Pt | RBC | Ord | |||
| 2022-11-07 | 101097-4 | JAHK Ab [Presence] in Serum or Plasma | JAHK Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101095-8 | IFC Ab [Presence] in Serum or Plasma | IFC Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101096-6 | Jo sup(a) Ab [Presence] in Serum or Plasma | J little o super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101094-1 | In^a Ab [Presence] in Serum or Plasma | I little n super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101093-3 | Hut Ab [Presence] in Serum or Plasma | H little u little t Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101092-5 | Hr^B Ab Ab [Presence] in Serum or Plasma | H little r super B Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101090-9 | Ge4 Ab [Presence] in Serum or Plasma | G little e4 Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101091-7 | Hr^s Ab [Presence] in Serum or Plasma | H little r super little s Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101089-1 | Ge3 Ag [Presence] on Red Blood Cells | G little e3 Ag | PrThr | Pt | RBC | Ord | |||
| 2022-11-07 | 101088-3 | Ge3 Ab [Presence] in Serum or Plasma | G little e3 Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101087-5 | Ge2 Ag [Presence] on Red Blood Cells | G little e2 Ag | PrThr | Pt | RBC | Ord | |||
| 2022-11-07 | 101085-9 | Ge1 Ab [Presence] in Serum or Plasma | G little e1 Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101086-7 | Ge2 Ab [Presence] in Serum or Plasma | G little e2 Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101084-2 | FPTT Ab [Presence] in Serum or Plasma | FPTT Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101083-4 | Ab [Presence] in Serum or Plasma | F little y5 Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101082-6 | Evans Ab [Presence] in Serum or Plasma | Evans Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101080-0 | En^a Ab [Presence] in Serum or Plasma | E little n super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101081-8 | Es^a Ab [Presence] in Serum or Plasma | E little s super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101079-2 | DAK Ab [Presence] in Serum or Plasma | DAK Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101078-4 | Dw Ab [Presence] in Serum or Plasma | D little w Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101077-6 | Dr^a Ab [Presence] in Serum or Plasma | D little r super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101075-0 | Crawford Ab [Presence] in Serum or Plasma | Crawford Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101076-8 | Dh^a Ab [Presence] in Serum or Plasma | D little h super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101074-3 | CEVF Ab [Presence] in Serum or Plasma | CEVF Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101073-5 | CEST Ab [Presence] in Serum or Plasma | CEST Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101072-7 | CENR Ab [Presence] in Serum or Plasma | CENR Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101070-1 | CEAG Ab [Presence] in Serum or Plasma | CEAG Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101071-9 | CELO Ab [Presence] in Serum or Plasma | CELO Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101069-3 | CE Ab [Presence] in Serum or Plasma | CE Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101068-5 | Cs^ab Ag [Presence] on Red Blood Cells | C little s super little b Ag | PrThr | Pt | RBC | Ord | |||
| 2022-11-07 | 101066-9 | Cr^a Ab [Presence] in Serum or Plasma | C little r super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101067-7 | Cs^ab Ab [Presence] in Serum or Plasma | C little s super little b Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101065-1 | Co4 Ab [Presence] in Serum or Plasma | C little o4 Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101064-4 | Co3 Ag Ag [Presence] on Red Blood Cells | C little o3 Ag | PrThr | Pt | RBC | Ord | |||
| 2022-11-07 | 101062-8 | BARC Ab [Presence] in Serum or Plasma | BARC Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101063-6 | Co3 Ag Ab [Presence] in Serum or Plasma | C little o3 Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101061-0 | Be^a Ab [Presence] in Serum or Plasma | B little e super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-11-07 | 101060-2 | An^a Ab [Presence] in Serum or Plasma | A little n super little a Ab | PrThr | Pt | Ser/Plas | Ord | |||
| 2022-10-18 | 101059-4 | Geriatric medicine Letter | Letter | Find | Pt | {Setting} | Doc | Geriatric medicine | ||
| 2022-10-18 | 101058-6 | Geriatric medicine Team Conference note | Conference note | Find | Pt | {Setting} | Doc | Geriatric medicine.team | ||
| 2022-10-18 | 101057-8 | Psychiatry Telehealth Admission evaluation note | Admission evaluation note | Find | Pt | Telehealth | Doc | Psychiatry | ||
| 2022-10-18 | 101056-0 | Rapid response team Conference note | Conference note | Find | Pt | {Setting} | Doc | Rapid response team | ||
| 2022-10-18 | 101055-2 | Critical care medicine.team Conference note | Conference note | Find | Pt | {Setting} | Doc | Critical care medicine.team | ||
| 2022-10-18 | 101054-5 | Chiropody Outpatient Note | Note | Find | Pt | Outpatient | Doc | Chiropody | ||
| 2022-10-18 | 101053-7 | Obstetrics Midwife Evaluation note | Evaluation note | Find | Pt | {Setting} | Doc | Obstetrics.midwife | ||
| 2022-10-18 | 101052-9 | Osteopathic Medicine - CA Consult note | Consultation note | Find | Pt | {Setting} | Doc | Osteopathic Medicine - CA | ||
| 2022-10-18 | 101051-1 | Reproductive endocrinology and infertility Surgical operation note | Surgical operation note | Find | Pt | {Setting} | Doc | Reproductive endocrinology and infertility | ||
| 2022-10-18 | 101050-3 | Bariatric surgery Surgical operation note | Surgical operation note | Find | Pt | {Setting} | Doc | Bariatric surgery | ||
| 2022-10-18 | 101049-5 | Anesthesiology Surgical operation note | Surgical operation note | Find | Pt | {Setting} | Doc | Anesthesiology | ||
| 2022-10-18 | 101048-7 | Hospitalist Consult note | Consultation note | Find | Pt | {Setting} | Doc | Hospitalist | ||
| 2022-10-18 | 101047-9 | Undersea and hyperbaric medicine Consult note | Consultation note | Find | Pt | {Setting} | Doc | Undersea and hyperbaric medicine | ||
| 2022-10-18 | 101046-1 | Hospitalist Progress note | Progress note | Find | Pt | {Setting} | Doc | Hospitalist | ||
| 2022-10-18 | 101045-3 | Hospitalist procedure note | Procedure note | Find | Pt | {Setting} | Doc | Hospitalist | ||
| 2022-10-18 | 101044-6 | Bariatric surgery procedure note | Procedure note | Find | Pt | {Setting} | Doc | Bariatric surgery | ||
| 2022-10-18 | 101043-8 | Urgent care center Consult note | Consultation note | Find | Pt | Urgent care center | Doc | {Role} | ||
| 2022-10-18 | 101041-2 | Aerospace medicine procedure note | Procedure note | Find | Pt | {Setting} | Doc | Aerospace medicine | ||
| 2022-10-18 | 101042-0 | Urgent care center Progress note | Progress note | Find | Pt | Urgent care center | Doc | {Role} | ||
| 2022-10-18 | 101040-4 | Integrative medicine procedure note | Procedure note | Find | Pt | {Setting} | Doc | Integrative medicine | ||
| 2022-10-18 | 101039-6 | Aerospace medicine Progress note | Progress note | Find | Pt | {Setting} | Doc | Aerospace medicine | ||
| 2022-10-18 | 101038-8 | Aerospace medicine Consult note | Consultation note | Find | Pt | {Setting} | Doc | Aerospace medicine | ||
| 2022-10-18 | 101037-0 | Chiropody Progress note | Progress note | Find | Pt | {Setting} | Doc | Chiropody | ||
| 2022-10-18 | 101036-2 | Integrative medicine Progress note | Progress note | Find | Pt | {Setting} | Doc | Integrative medicine | ||
| 2022-10-18 | 101035-4 | Osteopathic Medicine - CA procedure note | Procedure note | Find | Pt | {Setting} | Doc | Osteopathic Medicine - CA | ||
| 2022-10-18 | 101034-7 | Chiropractic medicine procedure note | Procedure note | Find | Pt | {Setting} | Doc | Chiropractic medicine | ||
| 2022-10-18 | 101033-9 | Chiropody procedure note | Procedure note | Find | Pt | {Setting} | Doc | Chiropody | ||
| 2022-10-18 | 101032-1 | Physician assistant Consult note | Consultation note | Find | Pt | {Setting} | Doc | Physician assistant | ||
| 2022-10-18 | 101031-3 | Chiropody Consult note | Consultation note | Find | Pt | {Setting} | Doc | Chiropody | ||
| 2022-10-18 | 101030-5 | Neuropsychology History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Neuropsychology | ||
| 2022-10-18 | 101029-7 | Hematology+Medical oncology History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Hematology+Medical oncology | ||
| 2022-10-18 | 101028-9 | Cardiac surgery History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Cardiac surgery | ||
| 2022-10-18 | 101027-1 | Child and adolescent psychology History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Child and adolescent psychology | ||
| 2022-10-18 | 101026-3 | Urgent care center History and physical note | History and physical note | Find | Pt | Urgent care center | Doc | {Role} | ||
| 2022-10-18 | 101025-5 | Sports medicine History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Sports medicine | ||
| 2022-10-18 | 101024-8 | Reproductive endocrinology and infertility History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Reproductive endocrinology and infertility | ||
| 2022-10-18 | 101023-0 | Orthotics prosthetics History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Orthotics prosthetics | ||
| 2022-10-18 | 101022-2 | Osteopathic Medicine - CA History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Osteopathic Medicine - CA | ||
| 2022-10-18 | 101021-4 | Optometry History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Optometry | ||
| 2022-10-18 | 101020-6 | Diabetology History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Diabetology | ||
| 2022-10-18 | 101019-8 | Nuclear medicine History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Nuclear medicine | ||
| 2022-10-18 | 101018-0 | Hospitalist History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Hospitalist | ||
| 2022-10-18 | 101017-2 | Kinesiotherapy History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Kinesiotherapy | ||
| 2022-10-18 | 101016-4 | Undersea and hyperbaric medicine History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Undersea and hyperbaric medicine | ||
| 2022-10-18 | 101015-6 | Surgical oncology History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Surgical oncology | ||
| 2022-10-18 | 101014-9 | Clinical cardiac electrophysiology History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Clinical cardiac electrophysiology | ||
| 2022-10-18 | 101013-1 | Community health care History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Community health care | ||
| 2022-10-18 | 101012-3 | Chiropractic medicine History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Chiropractic medicine | ||
| 2022-10-18 | 101011-5 | Chiropody History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Chiropody | ||
| 2022-10-18 | 101010-7 | Bariatric surgery History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Bariatric surgery | ||
| 2022-10-18 | 101009-9 | Integrative medicine History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Integrative medicine | ||
| 2022-10-18 | 101008-1 | Medical Aid in Dying History and physical note | History and physical note | Find | Pt | {Setting} | Doc | Medical aid in dying | ||
| 2022-10-18 | 101007-3 | Chiropody Discharge summary | Discharge summary note | Find | Pt | {Setting} | Doc | Chiropody | ||
| 2022-10-18 | 101006-5 | Osteopathic Medicine - CA Discharge summary | Discharge summary note | Find | Pt | {Setting} | Doc | Osteopathic Medicine - CA | ||
| 2022-10-18 | 101005-7 | Hospitalist Discharge summary | Discharge summary note | Find | Pt | {Setting} | Doc | Hospitalist | ||
| 2022-10-06 | 100999-2 | Somatotropin post dose insulin IV panel - Serum or Plasma | Somatotropin post dose insulin IV panel | - | Pt | Ser/Plas | - | |||
| 2022-10-06 | 100998-4 | Cortisol post dose insulin IV panel - Serum or Plasma | Cortisol post dose insulin IV panel | - | Pt | Ser/Plas | - | |||
| 2022-10-06 | 100997-6 | Respiratory Allergen Panel, Area 5 - Serum | Respiratory Allergen Panel, Area 5 | - | Pt | Ser | - | |||
| 2022-10-05 | 100996-8 | Neurofilament light chain [Mass/volume] in Cerebral spinal fluid | Neurofilament light chain | MCnc | Pt | CSF | Qn | |||
| 2022-10-04 | 100995-0 | Laceyella sacchari IgG Ab [Presence] in Serum | Laceyella sacchari Ab.IgG | PrThr | Pt | Ser | Ord | |||
| 2022-09-30 | 100993-5 | CD49 in Specimen Document by Flow cytometry (FC) | CD49d cell expression evaluation | Find | Pt | XXX | Doc | Flow cytometry | ||
| 2022-09-30 | 100994-3 | B-cell CD19 and CD20 subsets panel - Blood by Flow cytometry (FC) | B-cell CD19 & CD20 subsets panel | - | Pt | Bld | - | Flow cytometry | ||
| 2022-09-30 | 100992-7 | CD20 cells in Specimen Document by Flow cytometry (FC) | CD20 cell expression evaluation | Find | Pt | XXX | Doc | Flow cytometry | ||
| 2022-09-30 | 100991-9 | CD52 cells in Specimen Document by Flow cytometry (FC) | CD52 cell expression evaluation | Find | Pt | XXX | Doc | Flow cytometry | ||
| 2022-09-30 | 100990-1 | Fathers Blood group antigens panel | Blood group antigens panel | - | Pt | RBC^Father | - | |||
| 2022-09-30 | 100989-3 | Phosphoglucomutase [Enzymatic activity/volume] in Leukocytes | Phosphoglucomutase | CCnc | Pt | WBC | Qn | |||
| 2022-09-30 | 100988-5 | Phosphoglucomutase [Enzymatic activity/volume] in Fibroblast | Phosphoglucomutase | CCnc | Pt | Fibroblasts | Qn | |||
| 2022-09-30 | 100987-7 | Lymphocyte T-cell and B-cell and Natural killer subsets panel - Cerebral spinal fluid | Lymphocyte T-cell & B-cell & Natural killer subsets panel | - | Pt | CSF | - | |||
| 2022-09-29 | 100986-9 | HIV integrase failed codons by Genotype method | HIV integrase failed codons | Prid | Pt | Isolate | Nom | Genotyping | ||
| 2022-09-29 | 100985-1 | HIV protease failed codons by Genotype method | HIV protease failed codons | Prid | Pt | Isolate | Nom | Genotyping | ||
| 2022-09-29 | 100984-4 | HIV 1 group M RNA genotype by Genotype method | HIV 1 group M RNA genotype | Prid | Pt | Isolate | Nom | Genotyping | ||
| 2022-09-29 | 100983-6 | HIV reverse transcriptase failed codons by Genotype method | HIV reverse transcriptase failed codons | Prid | Pt | Isolate | Nom | Genotyping | ||
| 2022-09-23 | 100982-8 | Varicella zoster virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | Varicella Zoster Virus DNA | LnCnc | Pt | XXX | Qn | Probe.amp.tar | ||
| 2022-09-23 | 100981-0 | Parvovirus B19 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | Parvovirus B19 DNA | LnCnc | Pt | XXX | Qn | Probe.amp.tar | ||
| 2022-09-23 | 100980-2 | BK virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | BK Virus DNA | LnCnc | Pt | CSF | Qn | Probe.amp.tar | ||
| 2022-09-22 | 100979-4 | Atopobium vaginae DNA [Presence] in Urine by NAA with probe detection | Atopobium vaginae DNA | PrThr | Pt | Urine | Ord | Probe.amp.tar | ||
| 2022-09-08 | 100978-6 | Thyroxine.free.gestational [Moles/volume] in Serum or Plasma by Immunoassay | Thyroxine.free.gestational | SCnc | Pt | Ser/Plas | Qn | IA | ||
| 2022-09-08 | 100977-8 | JC virus Ab Index in Serum or Plasma by Immunoassay | JC virus Ab Index | ACnc | Pt | Ser/Plas | Qn | IA | ||
| 2022-09-02 | 100976-0 | Eosinophil derived neurotoxin [Mass/volume] in Serum or Plasma | Eosinophil derived neurotoxin | MCnc | Pt | Ser/Plas | Qn | |||
| 2022-09-02 | 100975-2 | Induced abortion method | Induced abortion method | Type | Pt | ^Patient | Nom | * | ||
| 2022-08-29 | 100974-5 | Influenza virus B RNA [Presence] in Nose by NAA with non-probe detection | Influenza virus B RNA | PrThr | Pt | Nose | Ord | Non-probe.amp.tar | ||
| 2022-08-29 | 100973-7 | Influenza virus A RNA [Presence] in Nose by NAA with non-probe detection | Influenza virus A RNA | PrThr | Pt | Nose | Ord | Non-probe.amp.tar | ||
| 2022-08-29 | 100972-9 | Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection | Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel | - | Pt | Nose | - | Non-probe.amp.tar | ||
| 2022-08-23 | 100971-1 | Clinical record panel | Clinical record panel | - | Pt | ^Patient | - | |||
| 2022-08-15 | 100970-3 | Portable medical order completion information | Portable medical order completion information | - | - | ^Patient | - | POLST | ||
| 2022-08-11 | 100969-5 | Pathology report additional specified observation in Specimen Narrative | Pathology report.additional specified observation | Find | Pt | Specimen | Nar |
TIP Click on headings to sort table by that column. Hold down Shift and click additional headings to add to sorting.
TIP In your web browser, use ControlF (or ⌘F on Mac) to find text on this page.
Receive notices of new and revised Special Use prerelease codes
Sign up to receive an email notification when new prerelease Special Use LOINC terms are created or revised.
For timely updates, follow @LOINC on Twitter. An RSS feed of new Special Use terms is also available.